UB
MRNA icon

UMB Bank’s Moderna MRNA Stock Holding History

UMB Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.7K Sell
1,253
-172
-12% -$8.9K ﹤0.01% 1097
2026
Q1 		$72.4K Buy
1,425
+146
+11% +$6.81K ﹤0.01% 1110
2025
Q4 		$37.7K Buy
1,279
+82
+7% +$2.23K ﹤0.01% 1343
2025
Q3 		$30.9K Sell
1,197
-81
-6% -$2.26K ﹤0.01% 1310
2025
Q2 		$35.3K Buy
1,278
+171
+15% +$4.5K ﹤0.01% 1228
2025
Q1 		$31.4K Buy
1,107
+336
+44% +$11.9K ﹤0.01% 1220
2024
Q4 		$32.1K Buy
771
+219
+40% +$10.5K ﹤0.01% 1085
2024
Q3 		$36.9K Sell
552
-81
-13% -$7.44K ﹤0.01% 971
2024
Q2 		$75.2K Buy
633
+267
+73% +$33.8K ﹤0.01% 749
2024
Q1 		$39K Buy
366
+201
+122% +$20.3K ﹤0.01% 877
2023
Q4 		$16.4K Buy
165
+41
+33% +$3.45K ﹤0.01% 1133
2023
Q3 		$12.8K Sell
124
-96
-44% -$10.7K ﹤0.01% 1209
2023
Q2 		$26.7K Hold
220
– – ﹤0.01% 1009
2023
Q1 		$33.8K Sell
220
-4
-2% -$660 ﹤0.01% 942
2022
Q4 		$41K Sell
224
-14
-6% -$2.29K ﹤0.01% 898
2022
Q3 		$29K Sell
238
-77
-24% -$11.7K ﹤0.01% 1006
2022
Q2 		$45K Sell
315
-111
-26% -$15.9K ﹤0.01% 945
2022
Q1 		$73K Sell
426
-105
-20% -$17.7K ﹤0.01% 852
2021
Q4 		$135K Buy
+531
New +$155K ﹤0.01% 745

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

UMB Bank's MRNA Position: Q2 2026 in Review

UMB Bank reduced its Moderna (MRNA) stake by 12% in Q2 2026, selling an estimated $8.9K and leaving 1,253 shares worth $87.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

UMB Bank first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $135K in Q4 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • UMB Bank held 1,253 shares of Moderna worth $87.7K as of Q2 2026.
  • UMB Bank sold 172 Moderna shares in Q2 2026, an estimated $8.9K.
  • Moderna made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1097 holding.
  • UMB Bank first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Moderna position peaked at $135K in Q4 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.